AOD9604 is used by researchers as a tool compound in laboratory studies of metabolic and adipose tissue pathways
Across the SUSTAIN program, once-weekly subcutaneous semaglutide 1.0 mg reduced HbA 1c by 1.51.8% after 3056 weeks, which was significantly more than sitagliptin, liraglutide, exenatide extended release, dulaglutide, canagliflozin, or insulin glargine
These medications particularly benefit patients with a BMI of 30 or more, who face four to five times higher risk of heart disease, stroke, and diabetes 2
Sirtuin 1 and autophagy attenuate cisplatin-induced hair cell death in the mouse cochlea and zebrafish lateral line
[61], LBPs were used as an adjuvant to lymphokine-activated killer (LAK) cells and IL-2 therapy in patients with various cancers, including malignant melanoma, lung cancer, renal cell carcinoma, and colorectal carcinoma
doi: 10.1016/j.yhbeh.2006.06.028